 cytokin releas syndrom monoclon antibodi mice prevent high dose methylprednisolon hamster specif complex murin share mani properti induct cell activ vivo inject entail varieti patholog chang relat system releas cytokin effect cytokin releas syndrom differ dose methylprednisolon m-pd variou interv time mab administr high dose m-pd mg/kg mab complet inhibit system releas tnf-alpha As patholog chang hypothermia acut renal tubular necrosi fatti infiltr liver hypoglycemia protect effect m-pd toxic reduct mortal rate galactosamine-sensit mice inhibit releas cytokin m-pd immunosuppress ctl activ alloantigen inject mab administr high dose glucocorticoid prevent releas cytokin acut toxic mab similar protocol mitig cytokine-releas syndrom mab man